Clinical efficacy of arsenic trioxide in a patient with acute promyelocytic leukemia with recurrent central nervous system involvement.
Zappasodi
Patrizia
P
Rossi
Marianna
M
Ambaglio
Ilaria
I
Bernasconi
Paolo
P
Corso
Alessandro
A
Lazzarino
Mario
M
Castagnola
Carlo
C
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use*; D002490:Central Nervous System / Q000473:pathology*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D017254:Leukemic Infiltration / Q000473:pathology*; D008577:Meningeal Neoplasms / Q000188:drug therapy*; D010087:Oxides / Q000627:therapeutic use*; D012008:Recurrence; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide